Expression of ribozymes in gene transfer systems to modulate target RNA levels.
The possibility of designing ribozymes to cleave any specific target RNA has rendered them valuable tools in both basic research and therapeutic applications. In the therapeutics area, they have been exploited to target viral RNAs in infectious diseases, dominant oncogenes in cancers and specific somatic mutations in genetic disorders. Most notably, several ribozyme gene therapy protocols for HIV patients are already in Phase 1 trials. More recently, ribozymes have been used for transgenic animal research, gene target validation and pathway elucidation.
Welch
P J
PJ
Immusol Inc., San Diego, CA 92121, USA. pwelch@immusol.com
Barber
J R
JR
Wong-Staal
F
F
D000818:Animals; D030801:Animals, Genetically Modified; D001709:Biotechnology; D002478:Cells, Cultured; D019020:Directed Molecular Evolution; D015195:Drug Design; D015870:Gene Expression; D018014:Gene Transfer Techniques; D006801:Humans; D012313:RNA / Q000378:metabolism*; D016337:RNA, Catalytic / Q000235:genetics* / Q000378:metabolism*
D016337:RNA, Catalytic; D012313:RNA